DIN 02475391 — GANCICLOVIR FOR INJECTION USP 500 MG
GANCICLOVIR FOR INJECTION USP is a powder for solution of Ganciclovir marketed by STERIMAX INC. The full Ganciclovir monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02475391
- Brand name
- GANCICLOVIR FOR INJECTION USP
- Active ingredient
- Ganciclovir
- Strength
- 500 MG
- Dosage form
- POWDER FOR SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- STERIMAX INC
- Health Canada status
- MARKETED
- Drug class
- Antiviral agent (synthetic nucleoside analogue)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Ganciclovir products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02162695 | CYTOVENE | 500 MG | POWDER FOR SOLUTION | CHEPLAPHARM ARZNEIMITTEL GMBH | MARKETED |
| 02530546 | EYEZIRGAN | 0.15 % | GEL | LABORATOIRES THEA | MARKETED |
| 02537168 | GANCICLOVIR FOR INJECTION | 500 MG | POWDER FOR SOLUTION | FORMATIVE PHARMA INC. | MARKETED |
| 02404761 | GANCICLOVIR FOR INJECTION, USP | 500 MG | POWDER FOR SOLUTION | FRESENIUS KABI CANADA LTD | MARKETED |